Lichen International Limited
LICN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $10 | $16 | $20 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $10 | $16 | $20 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 4.3% | 17.6% | -1.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 61.9% | 61.2% | 59.7% | 59.7% |
| EBITDA | -$0 | $0 | $0 | $0 |
| % Margin | -4% | 32.7% | 33.6% | 40.1% |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -14.8% | 21% | 23.1% | 24.7% |
| EPS Diluted | -0.41 | 63.96 | 69.49 | 0.29 |
| % Growth | -100.6% | -8% | 23,862.1% | – |
| Operating Cash Flow | -$0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | $0 |